We only have this paper's title and publication details.
Read it at the sourcePreclinical PET imaging study reveals PARP inhibition attenuates neuroinflammation and demyelination in multiple sclerosis models, indicating TSPO PET serves as a sensitive treatment biomarker.
C]PBR28 PET imaging as a sensitive noninvasive biomarker of treatment response.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: